
YABAO PHARM.CORP disclosed the progress of its share repurchase, having repurchased a total of 6 million shares
YABAO PHARM.CORP announced the progress of its share repurchase through centralized bidding. The company's shareholders' meeting approved the repurchase proposal on May 16, 2025, with the repurchase period from May 16, 2025, to November 14, 2025, and an expected repurchase amount of 50 million to 100 million yuan, aimed at reducing registered capital. As of September 30, a total of 6 million shares have been repurchased, accounting for 0.86% of the total share capital, with a highest transaction price of 6.65 yuan/share and a lowest of 6.30 yuan/share, totaling a payment amount of 38,878,040 yuan

